SCHEMBL1498751

SCHEMBL1498751

O=Cc1ccc(OCCCBr)cc1Br

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.40
MAOB P27338 3/20 0.40
PRKDC P78527 1/20 0.40
ALDH1A1 P00352 3/20 0.39
TRIM24 O15164 1/20 0.38
TYR P14679 1/20 0.38
TRIM33 Q9UPN9 1/20 0.38
APP P05067 1/20 0.37
MAPT P10636 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
HPGD P15428 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
TUBB1 Q9H4B7 1/20 0.35
ERN1 O75460 1/20 0.35
ALDH2 P05091 1/20 0.35
MAOA P21397 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16020852 0.87 LMNA (0.47) LMNAMAOBPRKDCALDH1A1SMN1; SMN2
SCHEMBL28095482 0.83 ERN1 (0.50) LMNAPRKDCALDH1A1TRIM24TYR
SCHEMBL25374930 0.83 CA1 (0.48) LMNAPRKDCALDH1A1TRIM24TYR
SCHEMBL30983963 0.82 TDP1 (0.46) ALDH1A1SMN1; SMN2HPGDERN1
SCHEMBL15145284 0.79 LMNA (0.59) LMNAPRKDCALDH1A1TRIM24TYR
SCHEMBL30091707 0.78 LMNA (0.43) LMNAMAOBPRKDCALDH1A1TRIM24
SCHEMBL22272552 0.78 LMNA (0.43) LMNAMAOBPRKDCALDH1A1TRIM24
SCHEMBL13127068 0.78 LTA4H (0.46) ALDH1A1SMN1; SMN2ERN1
SCHEMBL16873694 0.78 TYR (0.54) MAOBTRIM24TYRTRIM33MAPT
SCHEMBL21114075 0.78 MAOB (0.38) MAOBL3MBTL1ERN1ALDH2MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110124597-A1 BORON CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2011-05-26 US disclosed
US-20110124597-A1 BORON CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2011-05-26 US disclosed
US-20110124597-A1 BORON CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2011-05-26 US disclosed
WO-2011037731-A1 BORON CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2011-03-31 WO disclosed
WO-2011037731-A1 BORON CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2011-03-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110124597-A1 BORON CONTAINING SMALL MOLECULES BCL6B, BCL6, BLVRB LMNA 4328/4885MAOB 1879/4885PRKDC 4703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.